Open Access
ARTICLE
Circulating tumor cells: Biological features and survival mechanisms
XIAOFENG LI1, JINYANG ZHENG2, JINFENG ZHU3, XIN HUANG4, HUANHUAN ZHU5, BINGDI CHEN6,*
1 Department of Oncology, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, China
2 Department of Pathology, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, China
3 Department of Medical Oncology, Affiliated Quanzhou First Hospital of Fujian Medical University, Quanzhou, China
4 Department of Dermatology, School of Medicine, Tongji Hospital, Tongji University, Shanghai, China
5 Department of Central Laboratory, Shanghai Tenth People’s Hospital, Shanghai, China
6 Shanghai East Hospital, The Institute for Biomedical Engineering & Nano Science, Tongji University School of Medicine, Shanghai, China
* Corresponding Author: Bingdi Chen,
(This article belongs to the Special Issue: Expert Opinions and Future Trends on Stem Cells, Biomaterials and Growth Factors)
BIOCELL 2023, 47(8), 1771-1781. https://doi.org/10.32604/biocell.2023.028343
Received 13 December 2022; Accepted 06 February 2023; Issue published 28 August 2023
Abstract
Circulating tumor cells (CTCs) are neoplastic cells that are detached from primary tumors and enter
circulation. Enumeration and characterization of CTCs are of significance in cancer diagnosis, prognosis, and
treatment monitoring. CTC survival in the bloodstream is a limiting step for the development of metastases in distant
organs. Recent technological advances, especially in single-cell molecular analyses have uncovered heterogeneous CTC
survival mechanisms. Undergoing epithelial-to-mesenchymal transition (EMT), increasing stem cell-like properties,
and forming cell clusters enable CTCs to adapt to the harsh microenvironment of the circulation. Expressing and
releasing several immunosuppressive molecules help CTCs escape from anti-cancer immune mechanisms. This review
article summarizes the biological characteristics of CTCs and focuses on the recent understanding of the mechanisms
by which CTCs survive in circulation. Additionally, the clinical and therapeutic implications of CTCs are discussed.
Keywords
Cite This Article
APA Style
LI, X., ZHENG, J., ZHU, J., HUANG, X., ZHU, H. et al. (2023). Circulating tumor cells: biological features and survival mechanisms. BIOCELL, 47(8), 1771-1781. https://doi.org/10.32604/biocell.2023.028343
Vancouver Style
LI X, ZHENG J, ZHU J, HUANG X, ZHU H, CHEN B. Circulating tumor cells: biological features and survival mechanisms. BIOCELL . 2023;47(8):1771-1781 https://doi.org/10.32604/biocell.2023.028343
IEEE Style
X. LI, J. ZHENG, J. ZHU, X. HUANG, H. ZHU, and B. CHEN "Circulating tumor cells: Biological features and survival mechanisms," BIOCELL , vol. 47, no. 8, pp. 1771-1781. 2023. https://doi.org/10.32604/biocell.2023.028343